NGT HealthCare II is a Nazareth, Israel-based venture capital fund investing in early-stage healthcare and life sciences companies in Israel. It focuses on medical devices, biotechnology, pharmaceuticals, bio-convergence, diagnostics and health technology, with an impact-oriented model that emphasizes structured risk reduction, non-dilutive leverage through Israel’s Innovation Authority, and connections with universities, hospitals and research institutions.